Alkermes is a biopharmaceutical company. Co.'s products include: ARISTADA, which is an extended-release injectable suspension for the treatment of schizophrenia; VIVITROL, which is for the treatment of alcohol dependence and for the prevention of relapse to opioid dependence; INVEGA SUSTENNA/XEPLION, and RISPERDAL CONSTA, which is for the treatment of schizophrenia and for the treatment of schizoaffective disorder; AMPYRA/FAMPYRA, which is a treatment to improve walking in adults with multiple sclerosis; and BYDUREON is for the treatment of type 2 diabetes. Co.'s product candidate include Aripiprazole Lauroxil Two-Month Dose for the treatment of schizophrenia, among others.

Brightcove is a provider of cloud-based services for video. The company's products and services include: Brightcove Video Cloud, which is an online video platform to publish and distribute video to Internet-connected devices; Brightcove Zencoder, which is a cloud-based video encoding service; Brightcove SSAI, which is a cloud-based ad insertion and video stitching service; Brightcove Player, which is a cloud-based service for creating and managing video player experiences; Brightcove OTT Flow, which deploy direct-to-consumer, live and on-demand video services across platforms; Brightcove Video Marketing, which is an offering of Video Cloud, Brightcove Gallery (Gallery), and Brightcove Social.

Calumet Specialty Product Partners is a holding company. Through its subsidiaries, the company is an independent producer of hydrocarbon products in North America. In its specialty products segment, the company processes crude oil and other feedstocks into a variety of customized lubricating oils, white mineral oils, solvents, petrolatums and waxes. The company's specialty products are sold to customers who purchase them as raw material components for basic industrial, consumer and automotive goods. In its fuel products segment, the company processes crude oil into fuel and fuel-related products, including gasoline, diesel, jet fuel, asphalt and heavy fuel oils, and resells purchased crude oil to third party customers.

Coty and its subsidiaries are a beauty company. The company manufactures, markets, sells and distributes beauty products, including fragrances, color cosmetics, hair care products and skin and body related products. The company is organized into three divisions, which is also its operating and reportable segments: Consumer Beauty, Luxury and Professional Beauty. Consumer Beauty is primarily focused on color cosmetics, retail hair coloring and styling products, body care and mass fragrances. Luxury is primarily focused on fragrances, skincare and cosmetics. Professional Beauty is primarily focused on hair and nail care products for salon personnel.

GlycoMimetics is a clinical stage biotechnology company focused on the discovery and development of glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a main role. The company is developing uproleselan, a specific E-selectin inhibitor, to be used in combination with chemotherapy to treat patients with acute myeloid leukemia and other hematologic cancers. The company is also developing an additional drug candidate, GMI-1359, that simultaneously targets both E-selectin and a chemokine receptor known as CXCR4.

Universal Display is engaged in the research, development and commercialization of organic light emitting diode (OLED) technologies and materials for use in displays and lighting applications. The company manufactures and sells its proprietary OLED materials to customers for evaluation and use in commercial OLED products. The company also enters into agreements with manufacturers of OLED display and lighting products under which the company grants them licenses to practice under the company's patents and to use the company's proprietary know-how. At the same time, the company works with these and other companies that are evaluating the company's OLED technologies and materials for possible use in commercial OLED display and lighting products.

Varonis System provides data security and analytics. The company's software enables enterprises to protect data stored on premises and in the cloud: sensitive files and emails; confidential personal data; financial records; strategic and product plans; and other intellectual property. The Varonis Data Security Platform helps enterprises protect data against insider threats and cyberattacks. The company's products enable enterprises to analyze data, account activity and user behavior to detect attacks. The company's Data Security Platform prevents or limits unauthorized use of sensitive information, prevents potential cyberattacks and limits others by locking down sensitive and stale data.

Vistra Energy operates an integrated retail and generation business in markets throughout the U.S. Through its subsidiaries, the company is engaged in electricity market activities, including electricity generation, wholesale energy sales and purchases, commodity risk management and retail sales of electricity. The company has six segments: Retail, ERCOT, PJM, NY/NE (comprising NYISO and ISO-NE), MISO and Asset Closure. The Retail segment is engaged in retail sales of electricity and related services. The ERCOT, PJM, NY/NE and MISO segments are engaged in electricity generation, among others. The Asset Closure segment is engaged in the decommissioning and reclamation of retired plants and mines.

Wrap Technologies is a developer of security products designed for use by law enforcement and security personnel. The company's first product is the BolaWrap 100 remote restraint device. The BolaWrap 100 is a hand-held remote restraint device that discharges an eight-foot bola style Kevlar? tether to entangle an individual at a range of 10 to 25 feet. The BolaWrap 100 provides law enforcement a tool to remotely engage and temporarily control individuals. The BolaWrap 100 is designed to provide remote restraint while other use of force continuum options remain open. The design provides a range of latitude of accuracy to engage and restrain targeted legs or arms of a subject.